Plain-English translation of NCT04720560 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how your body's immune system — specifically cells called regulatory B cells — may play a role in developing fatty liver disease. This study involves examining blood and health information from adults diagnosed with fatty liver disease to understand why some people develop this condition and how it progresses.
Fatty liver disease is becoming increasingly common and can lead to serious liver damage or failure over time. However, doctors don't yet fully understand why some people develop this condition or how to predict who will get worse. By studying immune cells, researchers hope to discover new ways to diagnose and treat the disease earlier.
You likely qualify if…
You likely don't qualify if…
As a participant, you would likely have blood drawn and possibly undergo imaging tests or biopsies to assess your liver. Your medical history, laboratory results, and imaging findings would be collected and analyzed by the research team. The study aims to enroll 174 participants total, and you would be contributing your health information to help researchers understand the immune system's role in fatty liver disease.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Egypt
Enrollment target
~174 participants
Started
December 2023
Primary completion
September 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Amira Mohamed, PhD
Assiut University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.